Medicure Inc. (OTCMKTS:MCUJF) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $2.91 and traded as low as $2.46. Medicure shares last traded at $2.46, with a volume of 606 shares changing hands.

The firm has a market cap of $27.44 million, a price-to-earnings ratio of -18.14 and a beta of 0.32. The business has a 50 day moving average of $2.85 and a 200 day moving average of $3.27.

Medicure (OTCMKTS:MCUJF) last issued its quarterly earnings results on Tuesday, November 26th. The company reported ($0.03) earnings per share (EPS) for the quarter. Medicure had a negative return on equity of 3.55% and a negative net margin of 11.31%. The business had revenue of $4.18 million during the quarter.

About Medicure (OTCMKTS:MCUJF)

Medicure Inc, a cardiovascular pharmaceutical company, engages in the research, clinical development, and commercialization of human therapeutics in Canada, the United States, and Barbados. The company primarily markets and sells AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction, as well as AGGRASTAT high-dose bolus regimen for the reduction of thrombotic cardiovascular events in patients with non ST elevated acute coronary syndrome.

Read More: Price to Earnings Ratio (PE) Basics

Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.